Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-(4-(n-tert-butylcarbamoyl)-2-methoxybenzenesulfonyl)-5-ethoxy-3-spiro(4-(2-morpholinoethoxy)cyclohexane)indoline-2-one, Phosphate Monohydrate Cis-isomer
2. 1-(4-(n-tert-butylcarbamoyl)-2-methoxybenzenesulfonyl)-5-ethoxy-3-spiro-(4-(2-morpholinoethoxy)cyclohexane)indol-2-one Fumarate
3. Satavaptan
4. Sr 121463a
5. Sr-121463
6. Sr-121463b
7. Sr121463b
1. Sr 121463b
2. Sr-121463b
3. Ey1272i0w2
4. 308145-17-7
5. Benzamide, N-(1,1-dimethylethyl)-4-((cis-5'-ethoxy-4-(2-(4-morpholinyl)ethoxy)-2'-oxospiro(cyclohexane-1,3'-(3h)indol)-1'(2'h)-yl)sulfonyl)-3-methoxy-, Phosphate (1:1)
6. Sr121463b
7. Unii-ey1272i0w2
8. Satavaptan Phosphate [who-dd]
9. Q27277421
| Molecular Weight | 741.8 g/mol |
|---|---|
| Molecular Formula | C33H48N3O12PS |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 11 |
| Exact Mass | 741.26963215 g/mol |
| Monoisotopic Mass | 741.26963215 g/mol |
| Topological Polar Surface Area | 210 Ų |
| Heavy Atom Count | 50 |
| Formal Charge | 0 |
| Complexity | 1170 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antidiuretic Hormone Receptor Antagonists
Endogenous compounds and drugs that inhibit or block the activity of ANTIDUIRETIC HORMONE RECEPTORS. (See all compounds classified as Antidiuretic Hormone Receptor Antagonists.)
ABOUT THIS PAGE
A Satavaptan Phosphate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Satavaptan Phosphate, including repackagers and relabelers. The FDA regulates Satavaptan Phosphate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Satavaptan Phosphate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Satavaptan Phosphate supplier is an individual or a company that provides Satavaptan Phosphate active pharmaceutical ingredient (API) or Satavaptan Phosphate finished formulations upon request. The Satavaptan Phosphate suppliers may include Satavaptan Phosphate API manufacturers, exporters, distributors and traders.
click here to find a list of Satavaptan Phosphate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Satavaptan Phosphate DMF (Drug Master File) is a document detailing the whole manufacturing process of Satavaptan Phosphate active pharmaceutical ingredient (API) in detail. Different forms of Satavaptan Phosphate DMFs exist exist since differing nations have different regulations, such as Satavaptan Phosphate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Satavaptan Phosphate DMF submitted to regulatory agencies in the US is known as a USDMF. Satavaptan Phosphate USDMF includes data on Satavaptan Phosphate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Satavaptan Phosphate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Satavaptan Phosphate suppliers with USDMF on PharmaCompass.
Satavaptan Phosphate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Satavaptan Phosphate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Satavaptan Phosphate GMP manufacturer or Satavaptan Phosphate GMP API supplier for your needs.
A Satavaptan Phosphate CoA (Certificate of Analysis) is a formal document that attests to Satavaptan Phosphate's compliance with Satavaptan Phosphate specifications and serves as a tool for batch-level quality control.
Satavaptan Phosphate CoA mostly includes findings from lab analyses of a specific batch. For each Satavaptan Phosphate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Satavaptan Phosphate may be tested according to a variety of international standards, such as European Pharmacopoeia (Satavaptan Phosphate EP), Satavaptan Phosphate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Satavaptan Phosphate USP).
LOOKING FOR A SUPPLIER?
